Imuldosa
Ustekinumab-srlf · Accord BioPharma Inc.
PRESCRIPTION ONLY (USA)Imuldosa ingredients
| Active ingredient | Strength |
|---|---|
| Ustekinumab-Srlf | 130 mg/26mL, 90 mg/mL, 45 mg/.5mL |
What Imuldosa is used for
Imuldosa is a specialist medicine (interleukin-12 antagonist, interleukin-23 antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Imuldosa
- Generic name
- Ustekinumab-srlf
- Made by
- Accord BioPharma Inc.
- Forms
- Injection
- Given
- Intravenous, Subcutaneous
- Drug class
- Interleukin-12 Antagonist, Interleukin-23 Antagonist
- FDA approval
- Biologic licence (BLA) BLA761364
- On the US market since
- 2024
Official information
- Imuldosa prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Ustekinumab-srlf)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Imuldosa?
Imuldosa (Ustekinumab-srlf) is a specialist medicine made by Accord BioPharma Inc., approved by the US FDA.
What are the ingredients of Imuldosa?
Imuldosa contains Ustekinumab-Srlf (130 mg/26mL, 90 mg/mL, 45 mg/.5mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA